London, June 13, 2026, 23:04 (BST).
- Babcock International closed higher on Friday. Latest Hargreaves Lansdown figures show the stock quoted at 1,033.0p to 1,033.5p, up 6.0p, or 0.58%.
- Babcock’s next big event is its FY26 results set for June 22. Investors are waiting for audited figures on the Type 31 frigate charge and any FY27 outlook.
- Bulls point to defence and nuclear demand, cash flow and buybacks. Bears flag fixed-price contract overruns as a drag on margins.
Babcock International Group PLC finished the week stronger, with shares up as UK stocks advanced and investors waited for the company’s full-year numbers. Late Hargreaves Lansdown data had the FTSE 100 name up 6.0p, or 0.58%, quoting at 1,033.0p to sell and 1,033.5p to buy after the close. The FTSE 100 itself jumped 1.63% to 10,471.72. Reuters said UK blue chips moved higher Friday on the back of lower oil prices and optimism over a possible U.S.-Iran peace deal.
Babcock sits in a tight spot as the shares hold between solid operational results and lingering trouble from a risky contract. In May, the company guided for FY26 revenue of £5.27 billion, but that figure drops by around £100 million due to a revenue reversal on the Type 31 programme. Underlying operating profit, which management uses to get at recurring earnings, came in at £433 million before the Type 31 hit, and £293 million after, according to the company.
Type 31 frigate is still hanging over sentiment. Babcock took a £140 million charge tied to extra rework and design costs for the Royal Navy job. Reuters said total losses on the fixed-price deal now top £300 million. With fixed-price contracts, Babcock eats any extra costs, so investors are eyeing if this move draws a line under the problem or if more charges could hit.
Babcock still has bulls making the case. The company posted 10% organic revenue growth at constant currency and said underlying free cash flow rose to £262 million. Net debt is down to £329 million. Free cash flow, used for dividends, paying down debt, and buybacks, matters in the numbers. Babcock finished a £200 million buyback, announced another £200 million on the way, and kept FY27 guidance steady. About 70% of expected FY27 revenue was already under contract as of April 1.
Babcock’s backlog dropped to £9.6 billion from £10.4 billion. The Type 31 hit pulled reported underlying operating margin down to 5.7% from the earlier 8.2%. Cash costs will be spread out over the rest of the programme. Analysts quoted by Proactive Investors stayed supportive after the May update, but pointed to Type 31 as an ongoing issue, especially since the full-year audit got pushed to late June for the new estimates.
Babcock’s next big event is the June 22 FY26 results presentation. Investors want clarity on three points: a clean audit, whether FY27 guidance holds, and tighter detail about the remaining Type 31 cash outflow. The announcement will coincide with a management handover as David Lockwood is set to retire by the end of 2026, with deputy chief executive Harry Holt, ex-head of Babcock’s Nuclear sector, lined up to take over.
Babcock is drawing some interest from investors ready to take on defence-contract execution risk, but it’s not cheap for the risk. Investors Chronicle data lists nine analysts with a median 12-month target of 1,400p, above the last price of 1,034p. Price targets range widely, from 750p up to 1,675p, showing analysts are split on the level of risk. MarketScreener’s consensus also has a Buy and puts the average target at £14.68. Bullish arguments lean on its defence exposure, nuclear business, buybacks and low leverage. The danger is another Type 31 hit could take the shine off margin hopes just as Babcock looks to keep momentum in its turnaround.
